...
首页> 外文期刊>Toxicological sciences: An official journal of the Society of Toxicology >Key components of the mode of action for hemangiosarcoma induction in pregabalin-treated mice: Evidence of increased bicarbonate, dysregulated erythropoiesis, macrophage activation, and increased angiogenic growth factors in mice but not in rats
【24h】

Key components of the mode of action for hemangiosarcoma induction in pregabalin-treated mice: Evidence of increased bicarbonate, dysregulated erythropoiesis, macrophage activation, and increased angiogenic growth factors in mice but not in rats

机译:普瑞巴林治疗的小鼠中血管肉瘤诱导作用模式的关键组成部分:小鼠中而非大鼠中碳酸氢根增加,红细胞生成失调,巨噬细胞活化和血管生成生长因子增加的证据

获取原文
获取原文并翻译 | 示例
           

摘要

In carcinogenicity studies, pregabalin increased hemangiosarcoma incidence in mice but not in rats. Investigative studies, ranging in length from 24 h to 12 months, were conducted in mice (1000 or 5000 mg/kg) and rats (900 mg/kg) to evaluate a potential mode-of-action scheme for tumor formation. Three areas were evaluated: (1) hematopoiesis (because endothelial and hematopoietic cells arise from the same precursor and hemangiosarcomas are primarily located in mouse hematopoietic tissues), (2) angiogenic growth factors (because increased angiogenic growth factors may stimulate vascular tumors), and (3) pulmonary/blood gas parameters (because hypoxia is a known driver for endothelial cell proliferation). In mice, pregabalin rapidly increased platelet and megakaryocyte counts, activated platelets and bone marrow erythrophages, decreased the myeloid-to-erythroid (M:E) ratio (49%), and produced bone marrow and splenic congestion and extramedullary hematopoiesis (EMH). Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor immunohistochemical staining were also increased in mouse bone marrow and spleen and vascular endothelial growth factor receptor 2 immunolabeling was increased in liver. Serum bicarbonate was increased within 24 h of pregabalin administration, persisted over time, and was accompanied by decreased respiratory rate (up to 34%) and increased partial pressure of carbon dioxide (pCO. 2), resulting in sustained metabolic alkalosis and elevated blood pH in mice. In contrast, in rats, pregabalin decreased overall bone marrow cellularity, including decreased number of megakaryocytes (24%) with no evidence of erythrophages, no change in M:E ratio, no EMH, and no increase in angiogenic growth factors or blood pH. Persistent alterations in serum bicarbonate, respiratory function, and blood gas parameters in mice, without adequate compensatory mechanisms, has the potential to create chronic tissue hypoxia, an accepted driver of endothelial cell proliferation.
机译:在致癌性研究中,普瑞巴林增加了小鼠中血管肉瘤的发病率,但没有增加大鼠中血管瘤的发病率。在小鼠(1000或5000 mg / kg)和大鼠(900 mg / kg)中进行了从24小时到12个月不等的调查研究,以评估肿瘤形成的潜在作用方式。评价了三个方面:(1)造血作用(因为内皮细胞和造血细胞来自相同的前体,而血管肉瘤主要位于小鼠造血组织中);(2)血管生成生长因子(由于增加的血管生成生长因子可能刺激血管肿瘤),以及(3)肺/血气参数(因为缺氧是内皮细胞增殖的已知驱动因素)。在小鼠中,普瑞巴林会迅速增加血小板和巨核细胞计数,激活血小板和骨髓红细胞噬菌体,降低骨髓与类红细胞(M:E)的比例(49%),并产生骨髓和脾充血和髓外造血(EMH)。小鼠骨髓和脾脏中的血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子的免疫组织化学染色也增加,肝脏中血管内皮生长因子受体2的免疫标记也增加。服用普瑞巴林后24小时内血清碳酸氢盐升高,并持续存在,并伴有呼吸频率下降(高达34%)和二氧化碳分压升高(pCO。2),导致持续的代谢性碱中毒和血液pH升高在小鼠中。相反,在大鼠中,普瑞巴林降低了总体骨髓细胞,包括减少的巨核细胞数量(24%),没有红斑的迹象,M:E比没有改变,EMH没有改变,血管生成因子或血液pH值也没有增加。在没有适当补偿机制的情况下,小鼠血清碳酸氢盐,呼吸功能和血气参数的持续变化有可能造成慢性组织缺氧,这是内皮细胞增殖的公认驱动力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号